Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Weight management is no easy task, but achieving and maintaining a healthy weight is important for your well-being, your diabetes management, and your overall health.
The FDA and the FTC sent warning letters to 10 companies falsely claiming to sell dietary supplements that could cure, treat, mitigate, or prevent diabetes. People are...
Kerendia (also known as finerenone) can reduce the risk of heart attacks, hospitalization for heart failure, and cardiovascular death for adults with chronic kidney...
​This international clinical trial is enrolling an estimated 1,224 participants who have been diagnosed with type 2 diabetes, age 18 or older. This study is...
How one clinic is integrating diabetes and heart health, focusing on comprehensive risk reduction, including medications that both lower blood glucose and protect the...
In this clinical trial, researchers are studying the effectiveness of dapagliflozin and saxagliptin in children and adolescents with type 2 diabetes. While these drugs...
When it comes to SGLT-2s and GLP-1s, there are several medicines available. Read below for more information on these therapies which have particular benefits for those...
The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other...
Learn about anti-CD3 therapy designed to slow or stop the progression of type 1 diabetes.
Juvenile Diabetes Research Foundation President and CEO Dr. Alan Lewis discusses the organization's priorities, one year in.
In a recent study, Novo Nordisk's next-generation basal insulin degludec was found to cause less hypoglycemia than Lantus. In early May, Novo Nordisk announced the...
Novo Nordisk continues to make headway in the development of Degludec and DegludecPlus, the company’s two new “next-generation” insulins. The company recently announced...
In early November, Kombiglyze, a pill combining DPP-4 inhibitor Onglyza and metformin, was approved by the FDA for type 2 diabetes. Onglyza was approved in July 2010...
In mid-April, the European Medicine Agency's Committee for Medicinal Products for Human Use (a committee called the "CHMP") recommended that Amylin/Lilly/Alkermes' once-...
The FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment.
In late 2010, Merck announced that it had acquired SmartCells, a small Massachusetts-based company that is developing a smart insulin product aptly named SmartInsulin...
People with diabetes are at significantly increased risk for kidney impairment or kidney failure. Kidney disease can complicate the treatment of type 2 diabetes because...
Type 1s and GLP-1s? diaTribe Editor-In-Chief Kelly Close tries Victoza and shares her remarkable results.
Earlier this month, Eli Lilly and the German pharmaceutical Boehringer Ingelheim (BI) announced a major partnership to co-develop and co-commercialize several of their...
Can Victoza help people with type 1 diabetes? See what Novo Nordisk has to say inside.

Pages